Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imaging clinically localized prostate cancer.

Rajveer S Purohit1, Katsuto Shinohara, Maxwell V Meng

  • 1Department of Urology, 400 Parnassus Avenue, A632, University of California-San Francisco, San Francisco, CA 94143-0738, USA. rajpu@itsa.ucsf.edu

The Urologic Clinics of North America
|May 9, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal cell carcinoma incidence and mortality in California: a population-based study of sociodemographic patterns and temporal trends from 1988 through 2019.

Lancet regional health. Americas·2026
Same author

A High Decipher Genomic Risk Score Is Associated with Major Pathological Progression in Patients Undergoing Active Surveillance for Prostate Cancer.

European urology oncology·2026
Same author

Functionally heterogeneous intratumoral CD4<sup>+</sup>CD8<sup>+</sup> double-positive T cells can give rise to single-positive T cells.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Determining Optimal Patient Selection for High-intensity Focused Ultrasound for Prostate Cancer.

European urology focus·2025
Same author

The Natural History of Confirmed Grade Group 1 Prostate Cancer Managed with Active Surveillance in the Modern Era.

European urology oncology·2025
Same author

Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expression.

Nature communications·2025
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Currently, no single radiographic test reliably stages prostate cancer locally. Future advancements may combine imaging methods, guided by risk models, to improve accuracy for this common cancer.

Area of Science:

  • Urology
  • Radiology
  • Medical Imaging

Background:

  • Accurate local staging of prostate cancer is crucial for treatment decisions.
  • Existing radiographic tests lack sufficient sensitivity and specificity for widespread use.
  • Conventional gray-scale transrectal ultrasound (TRUS) is standard for guiding biopsies.

Purpose of the Study:

  • To review current and emerging imaging modalities for prostate cancer local staging.
  • To assess the potential of advanced ultrasound and MRI techniques.
  • To provide guidance on the selective use of various imaging tests.

Main Methods:

  • Review of existing literature on prostate cancer imaging.
  • Discussion of conventional and novel ultrasound techniques (Doppler, 3D, contrast agents, elastography).

Related Experiment Videos

  • Evaluation of magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) for staging.

    • Main Results:

    • No single radiographic test is currently ideal for prostate cancer local staging.
    • Modified TRUS techniques show promise for improved accuracy.
    • Endorectal MRI and prostatic MRS may enhance staging specificity in selected patients.
    • Cross-sectional imaging and bone scans should be used selectively.

    Conclusions:

    • Future prostate cancer staging will likely involve a combination of imaging modalities.
    • Risk-stratification models will guide the utilization of these tests.
    • Selective application of advanced imaging techniques is recommended over routine use.